Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 22, 2015
Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccinationAnkit Mittal, Kai Schulze, Thomas Ebensen, et al.
Pharmaceutics|March 29, 2023
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEGMaria Victoria Sanchez, Thomas Ebensen, Kai Schulze, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2014
Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantationAnkit Mittal, Kai Schulze, Thomas Ebensen, et al.
Vaccine|July 20, 2019
The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cellsJulia Volckmar, Laura Knop, Sabine Stegemann-Koniszewski, et al.
Environmental Microbiology|June 9, 2012
Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinologyTetyana Yevsa, Thomas Ebensen, Barbara Fuchs, et al.
Ebiomedicine|July 30, 2017
Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation PathwayDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine DevelopmentDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
Pharmaceutics|February 4, 2021
Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal VaccinesDarío Lirussi, Sebastian Felix Weissmann, Thomas Ebensen, et al.
Vaccine|January 12, 2010
The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvantRimma Libanova, Thomas Ebensen, Kai Schulze, et al.
Plos One|August 21, 2014
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challengeMaria Victoria Sanchez, Thomas Ebensen, Kai Schulze, et al.
Pageof 8